Makary pushes bounds of FDA commissioner role on prices, drug reviews and personnel

Over the last decade, FDA commissioners have generally steered clear from the nitty-gritty of drug applications, the opinions of drug review staff, or trying to bend laws that prohibit the agency from attempting to influence ...